You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
McKesson
Dow
Moodys
Baxter

Last Updated: January 20, 2021

DrugPatentWatch Database Preview

Litigation Details for Mallinckrodt LLC v. Lupin Ltd (D. Del. 2012)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Mallinckrodt LLC v. Lupin Ltd
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Mallinckrodt LLC v. Lupin Ltd (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-08-30 1 the expiration of United States Patent No. 8,217,078 (“the ’078 patent”), which covers the use of PENNSAID…APOTEX’S DIRECT INFRINGEME(Il`(l)TU§:: IIJ.S. PATENT NO. 8,217,078 UNDER 35 U.S.C. § 271(€)(2)(A) 32. Plaintiffs…APOTEX’S INDUCEMENT OF INFRINGEMENT OF U.S. PATENT NO. 8,217,078 UNDER 35 U.S.C. 8 271(1)) 36. Plaintiffs…COUNT IV LUPIN’S DIRECT INFRINGEMENT OF U.S. PATENT NO. 8,217,078 UNDER 35 U.S.C. 5 271(el(Zl(Al 46. Plaintiffs…infringed and will induce infringement of U.S. Patent No. 8,217,078; B. A judgment pursuant to 35 U.S.C. § External link to document
2013-03-22 11 8,217,078 (“the ’078 patent”). Lupin admits that the Complaint purports to relate to Lupin Ltd.’s … APOTEX’S DIRECT INFRINGEMENT OF U.S. PATENT NO. 8,217,078 UNDER 35 U.S.C…APOTEX’S INDUCEMENT OF INFRINGEMENT OF U.S. PATENT NO. 8,217,078 UNDER 35 U.S.C. §… LUPIN’S DIRECT INFRINGEMENT OF U.S. PATENT NO. 8,217,078 UNDER 35 U.S.C…LUPIN’S INDUCEMENT OF INFRINGEMENT OF U.S. PATENT NO. 8,217,078 UNDER 35 U.S.C. External link to document
2014-01-28 57 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,217,078. (Attachments: # 1 …2012 28 January 2014 1:12-cv-01087 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Merck
Mallinckrodt
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.